Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Circ Heart Fail. 2015 Mar 17;8(3):533–541. doi: 10.1161/CIRCHEARTFAILURE.114.001915

Figure.

Figure

[A] Effective arterial elastance (Ea) was reduced at rest after 24 weeks treatment in subjects randomized to sildenafil (red) compared to placebo. [B] 24 week changes in endothelial function, assessed as the reactive hyperemia index (RHI) in placebo and sildenafil. Left ventricular contractility, assessed as [C] peak power index (PWR/EDV) and [D] stroke work index (SW/EDV) was reduced after 24 weeks treatment with sildenafil (red) as compared to placebo (black).